Clinical Trials Logo

Clinical Trial Summary

US Time-Harmonic Elastography for the Early Detection of Childhood Glomerulonephritis


Clinical Trial Description

Glomerulonephritis (GN) comprises a group of renal diseases characterized by glomerular and tubulointerstitial fibrosis secondary to glomerular inflammation and proliferation of the basement membrane, mesangial cells, or capillary endothelium triggered by immunologic mechanisms.(1) The glomerular filtration rate decreases with progression of chronic kidney disease (CKD), ultimately resulting in end-stage renal failure. Glomerulonephritis is the third most common cause of end-stage renal failure. Initial clinical signs of glomerulonephritis are nonspecific and subtle. Occasionally, affected patients present with hypertension, proteinuria, hematuria, raised serum creatinine level, weight gain, edema, or nephrotic syndrome.(2) The underlying pathologic changes are partly irreversible, and a prompt diagnosis with early initiation of treatment is of vital importance. The diagnosis is based on clinical, laboratory, and conventional US findings, whereas renal biopsy is considered the reference standard for a definitive diagnosis and fibrosis grading.(3,4) Unfortunately, this invasive procedure is associated with the risk of serious bleeding complications and therefore is not the method of choice for longitudinal monitoring. Elastography, a Novel imaging modality that estimates tissue stiffness, especially for superficial organs such as the breast and Thyroid. In recent years, ultrasound elastography (UE) has been demonstrated in the liver and has been applied widely in the diagnosis and evaluation of liver diseases, such as chronic hepatitis, alcoholic liver diseases, and non alcoholic fatty liver diseases.(5,6) To date, renal allograft stiffness (elasticity) has been evaluated by magnetic resonance elastography (MRE) and ultrasound elastography (UE). However, UE application for native renal diseases has not been well up till now.(7) Conventional renal ultrasonography may be appropriate to evaluate kidney size, as well as to assess the echogenicity of the renal cortex, exclude obstruction, and determine the extent of fibrosis. However, It has no significant role in diagnosis of GN. US time-harmonic elastography depicts abnormal renal stiffness in glomerulonephritis, particularly among patients with early disease and preserved renal function.(8,9,10) ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04582890
Study type Observational
Source Assiut University
Contact
Status Active, not recruiting
Phase
Start date April 30, 2021
Completion date October 30, 2022

See also
  Status Clinical Trial Phase
Completed NCT00001457 - Lamivudine for Chronic Hepatitis B Phase 2
Recruiting NCT05505955 - Study of HRS-5965 in Healthy Subjects and Subjects With Renal Insufficiency Phase 1
Recruiting NCT01240564 - The Nephrotic Syndrome Study Network (NEPTUNE) N/A
Active, not recruiting NCT05174221 - A Study of Mezagitamab in Adults With Primary Immunoglobulin A Nephropathy Receiving Stable Background Therapy Phase 1
Completed NCT00426348 - A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA Nephropathy Phase 4
Recruiting NCT04662723 - Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy. Phase 4
Completed NCT02700516 - Recurrent Glomerulonephritis After Renal Transplantation N/A
Recruiting NCT00862693 - Calcitriol in the Treatment of Immunoglobulin A Nephropathy Phase 4
Completed NCT00983034 - The Effects of Helicobacter Pylori Eradication on Proteinuria in Patients With Membranous Nephropathy N/A
Completed NCT00004990 - Once-A-Month Steroid Treatment for Patients With Focal Segmental Glomerulosclerosis Phase 2
Recruiting NCT04846010 - Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2 Phase 1/Phase 2
Terminated NCT04387448 - A Study of TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease Phase 2
Terminated NCT04950114 - An Open-Label, Long-term Study of GFB-887 in Patients With Glomerular Kidney Diseases Phase 2
Completed NCT00437463 - Treatment of Immunoglobulin A (IgA) Nephropathy by Angiotensin-Converting Enzyme (ACE) Inhibitor Phase 3
Terminated NCT02523768 - Prevention in Recipients With Primary IgA Nephropathy of Recurrence After Kidney Transplantation: ATG-F Versus Basiliximab as Induction Immunosuppressive Treatment Phase 4
Completed NCT00106561 - Using the Drug Spironolactone to Test If It Reduces Protein Leakage From the Kidney Phase 2/Phase 3
Completed NCT04733040 - Efficacy, Safety and PK/PD of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN) (NewPLACE) Phase 2
Completed NCT00001676 - Cyclophosphamide and Fludarabine to Treat Lupus Nephritis Phase 1
Recruiting NCT02063100 - Efficacy and Safety of Shenyankangfu Tablets for Primary Glomerulonephritis Phase 4
Completed NCT01093157 - A Dose Escalation Study of Long-acting ACTH Gel in Membranous Nephropathy Phase 1/Phase 2